Keywords: morphosys, sees, revenues, leap, germany, achieved, turnaround
MorphoSys sees 2004 revenues leap 44%
Article | 21 February 2005
Germany's MorphoSys has achieved a turnaround in its operating performance, reporting a 43.8% jump in 2004 revenues to 22.0 million euros ($28.5 million), resulting ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
